(Q34292002)

1 August 2017

1 reference

title

Biology of Kaposi's sarcoma (English)

1 reference

1 August 2017

Ensoli B

1

1 reference

1 August 2017

Sgadari C

2

1 reference

1 August 2017

Barillari G

3

1 reference

1 August 2017

Sirianni MC

4

1 reference

1 August 2017

Stürzl M

5

1 reference

1 August 2017

Monini P

6

1 reference

1 August 2017

1 July 2001

1 reference

European Journal of Cancer

1 August 2017

1 reference

1 August 2017

37

1 reference

1 August 2017

10

1 reference

1 August 2017

1251-1269

1 reference

Kaposi's sarcoma in Italy before and after the AIDS epidemic

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma in organ transplant recipients: report of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

The appearance of Kaposi sarcoma during corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma in mainland Tanzania: a report of 117 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's Sarcoma in Uganda: Geographic and Ethnic Distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Disseminated Kaposi's sarcoma syndrome in young homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Myopathy in McArdle's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma: a reversible hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

HTLV-III antibody testing in sperm donors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Evidence for multiclonality in multicentric Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Microsatellite instability in primary neoplasms from HIV + patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Monoclonal Origin of Multicentric Kaposi's Sarcoma Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Cultured, AIDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma and new herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Latent BK virus infection and Kaposi's sarcoma pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Immunological Studies in Kaposi's Sarcoma in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

The role of immunosuppression and immune-activation in classic Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Clinical aspects of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma in HIV-negative homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Sexual transmission and the natural history of human herpesvirus 8 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma after kidney transplantation. Report of complete remission of cutaneous and visceral involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

A histologic and flow cytometric study of Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Interleukin 1 is an autocrine regulator of human endothelial cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Inhibition of endothelial cell proliferation by gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Human herpesvirus 8 detection in nasal secretions and saliva

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Association of Kaposi's sarcoma associated herpesvirus (KSHV) DNA in bronchoalveolar lavage fluid of HIV infected individuals with bronchoscopically diagnosed tracheobronchial Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Human herpesvirus 8 DNA sequences in CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Identification of human herpesvirus 8-specific cytotoxic T-cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Human herpesvirus 8 cellular immune responses in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Mechanism of paclitaxel activity in Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900121-6

7 January 2021

10.1016/S0959-8049(01)00121-6

Identifiers

DOI

1 reference

release_quvcuq5grvdtbilbtszs4krujq

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/quvcuq5grvdtbilbtszs4krujq

24 November 2022

mapped directly with Wikidata item

1 reference